Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileFrank Martin Sacks, M.D.

TitleProfessor of Cardiovascular Disease Prevention
InstitutionHarvard T.H. Chan School of Public Health
DepartmentNutrition
AddressHarvard School of Public Health
Building 1, Room 203
665 Huntington Ave
Boston MA 02115
Phone617/432-1420
Fax617/432-3101
vCardDownload vCard (login for email)
Profile Picture
Other Positions
TitleProfessor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
DivisionChanning Division of Network Medicine


Collapse Biography 
Collapse awards and honors
20112011 Research Achievement Award

Collapse Overview 
Collapse overview
Dr. Sacks is involved in research and public policy in lipid disorders, hypertension, nutrition, and cardiovascular disease.

His research program is a combination of laboratory research on human lipoprotein metabolism, and clinical trials in nutrition and cardiovascular disease. The laboratory research concerns the acute and long term effects of dietary and drug treatments on the function of lipoproteins in humans; the function in humans of specific apolipoproteins in VLDL, LDL, and HDL including apoC-III and apoE; metabolic pathways for HDL subtypes involved in reverse cholesterol transport in humans; and epidemiology of the relation between lipoprotein particle types based on apolipoprotein composition and CVD.

Dr. Sacks was Chair of the Design Committee of the DASH study where the DASH diet was designed, and Chair of the Steering Committee for the DASH-Sodium trial. These multi center National Heart Lung and Blood Institute trials found major beneficial additive effects of low salt and a dietary pattern rich in fruits and vegetables on blood pressure. Dr. Sacks was Principal Investigator of an NIH funded trial on dietary approaches for weight loss and maintenance, the PoundsLost trial. In this trial, 4 diets varying in protein, carbohydrate and fat content were tested in 811 overweight people for 2 years. The diets had the same beneficial effects on weight loss, and all favorably affected risk factors for cardiovascular disease.

Dr. Sacks is active in national and international committees and conferences in dietary and drug treatments of dyslipidemia, and nutrition and health guidelines. . Dr. Sacks was a member of the National Cholesterol Education Program Adult Treatment Panel IV, the NIH advisory group that is developing new guidelines for treatment of dyslipidemia; and he was an external peer reviewer for the NIH of the current guidelines, Adult Treatment Panel III. He is a member of the Hypertriglyceridemia Guidelines Committee of the Endocrine Society. He is Chair of the American Heart Association Nutrition Committee that advises the AHA on nutrition policy. He is a member of the Lifestyle Working Group of the National Heart Lung and Blood Institute Clinical Guidelines for Reducing Cardiovascular Disease. Dr. Sacks teaches at Harvard School of Public Health as course director for nutritional biochemistry and for scientific writing, and at Brigham & Women’s Hospital on treatment of lipid disorders.

Dr. Sacks was the 2011 recipient of the American Heart Association’s Research Achievement Award for lifetime research accomplishments.

Dr. Sacks has published over 180 original research articles and 72 reviews, editorials, and letters.


Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
R01HL123917     (SACKS, FRANK M)Aug 25, 2014 - May 31, 2018
NIH/NHLBI
HDL Proteins and Coronary Heart Disease
Role: Principal Investigator

R01HL095964     (SACKS, FRANK M)Aug 1, 2010 - Jul 31, 2015
NIH/NHLBI
Dietary Fat and HDL Metabolism
Role: Principal Investigator

R01HL084568     (SACKS, FRANK M)Mar 1, 2007 - Feb 28, 2013
NIH/NHLBI
Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes
Role: Principal Investigator

U01HL073286     (SACKS, FRANK M)Sep 28, 2003 - Feb 28, 2010
NIH/NHLBI
Dietary Macronutrients and Weight Loss
Role: Principal Investigator

R01HL070159     (SACKS, FRANK M)Jul 28, 2003 - Jun 30, 2008
NIH/NHLBI
VLDL and LDL Particle Types as CHD Risk Factors
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Juraschek SP, Woodward M, Sacks FM, Carey VJ, Miller ER, Appel LJ. Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet. Hypertension. 2017 Nov; 70(5):923-929. PMID: 28993451.
    View in: PubMed
  2. Goni L, Sun D, Heianza Y, Wang T, Wang T, Cuervo M, Martinez JA, Shang X, Bray GA, Sacks FM, Qi L. Macronutrient-specific effect of the MTNR1B genotype on lipid levels in response to 2-year weight-loss diets. J Lipid Res. 2017 Oct 31. PMID: 29089366.
    View in: PubMed
  3. Han L, Ma W, Sun D, Heianza Y, Wang T, Zheng Y, Huang T, Duan D, Bray JGA, Champagne CM, Sacks FM, Qi L. Genetic variation of habitual coffee consumption and glycemic changes in response to weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Am J Clin Nutr. 2017 Nov; 106(5):1321-1326. PMID: 28931532.
    View in: PubMed
  4. Aroner SA, Yang M, Li J, Furtado JD, Sacks FM, Tjønneland A, Overvad K, Cai T, Jensen MK. Apolipoprotein C-III and High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III in Relation to Diabetes Risk. Am J Epidemiol. 2017 Sep 15; 186(6):736-744. PMID: 28520887.
    View in: PubMed
  5. Rosenson RS, Brewer HB, Barter PJ, Björkegren JLM, Chapman MJ, Gaudet D, Kim DS, Niesor E, Rye KA, Sacks FM, Tardif JC, Hegele RA. HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nat Rev Cardiol. 2017 Aug 10. PMID: 28795686.
    View in: PubMed
  6. Juraschek SP, Miller ER, Appel LJ, Christenson RH, Sacks FM, Selvin E. Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial. Diabet Med. 2017 Oct; 34(10):1407-1413. PMID: 28574153.
    View in: PubMed
  7. Heianza Y, Sun D, Wang T, Huang T, Bray GA, Sacks FM, Qi L. Starch Digestion-Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial. Diabetes. 2017 Sep; 66(9):2416-2423. PMID: 28659346.
    View in: PubMed
  8. Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, Miller M, Rimm EB, Rudel LL, Robinson JG, Stone NJ, Van Horn LV. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2017 Jul 18; 136(3):e1-e23. PMID: 28620111.
    View in: PubMed
  9. Apolzan JW, Myers CA, Champagne CM, Beyl RA, Raynor HA, Anton SA, Williamson DA, Sacks FM, Bray GA, Martin CK. Frequency of Consuming Foods Predicts Changes in Cravings for Those Foods During Weight Loss: The POUNDS Lost Study. Obesity (Silver Spring). 2017 Aug; 25(8):1343-1348. PMID: 28618170.
    View in: PubMed
  10. Kakarmath SS, Zack RM, Leyna GH, Fahimi S, Liu E, Fawzi WW, Lukmanji Z, Killewo J, Sacks F, Danaei G. Dietary determinants of serum total cholesterol among middle-aged and older adults: a population-based cross-sectional study in Dar es Salaam, Tanzania. BMJ Open. 2017 Jun 06; 7(5):e015028. PMID: 28588111.
    View in: PubMed
  11. He H, Sun D, Zeng Y, Wang R, Zhu W, Cao S, Bray GA, Chen W, Shen H, Sacks FM, Qi L, Deng HW. A Systems Genetics Approach Identified GPD1L and its Molecular Mechanism for Obesity in Human Adipose Tissue. Sci Rep. 2017 May 11; 7(1):1799. PMID: 28496128.
    View in: PubMed
  12. Melchior JT, Street SE, Andraski AB, Furtado JD, Sacks FM, Shute RL, Greve EI, Swertfeger DK, Li H, Shah AS, Lu LJ, Davidson WS. Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1. J Lipid Res. 2017 Jul; 58(7):1374-1385. PMID: 28476857.
    View in: PubMed
  13. Koch M, Furtado JD, Jiang GZ, Gray BE, Cai T, Sacks F, Tjønneland A, Overvad K, Jensen MK. Associations of anthropometry and lifestyle factors with HDL subspecies according to apolipoprotein C-III. J Lipid Res. 2017 Jun; 58(6):1196-1203. PMID: 28365588.
    View in: PubMed
  14. Bray GA, Ryan DH, Johnson W, Champagne CM, Johnson CM, Rood J, Williamson DA, Sacks FM. Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial. Clin Obes. 2017 Jun; 7(3):166-175. PMID: 28340516.
    View in: PubMed
  15. Huang T, Zheng Y, Hruby A, Williamson DA, Bray GA, Shen Y, Sacks FM, Qi L. Dietary Protein Modifies the Effect of the MC4R Genotype on 2-Year Changes in Appetite and Food Craving: The POUNDS Lost Trial. J Nutr. 2017 Mar; 147(3):439-444. PMID: 28148682.
    View in: PubMed
  16. Liu G, Liang L, Bray GA, Qi L, Hu FB, Rood J, Sacks FM, Sun Q. Thyroid hormones and changes in body weight and metabolic parameters in response to weight loss diets: the POUNDS LOST trial. Int J Obes (Lond). 2017 Jun; 41(6):878-886. PMID: 28138133.
    View in: PubMed
  17. Ma W, Huang T, Heianza Y, Wang T, Sun D, Tong J, Williamson DA, Bray GA, Sacks FM, Qi L. Genetic Variations of Circulating Adiponectin Levels Modulate Changes in Appetite in Response to Weight-Loss Diets. J Clin Endocrinol Metab. 2017 Jan 01; 102(1):316-325. PMID: 27841942.
    View in: PubMed
  18. Lee LH, Andraski AB, Pieper B, Higashi H, Sacks FM, Aikawa M, Singh SA. Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins. Proteomics. 2017 Jan; 17(1-2). PMID: 27862954.
    View in: PubMed
  19. Juraschek SP, Miller ER, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM. Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial. BMJ Open Diabetes Res Care. 2016; 4(1):e000276. PMID: 27933186.
    View in: PubMed
  20. Livingstone KM, Celis-Morales C, Papandonatos GD, Erar B, Florez JC, Jablonski KA, Razquin C, Marti A, Heianza Y, Huang T, Sacks FM, Svendstrup M, Sui X, Church TS, Jääskeläinen T, Lindström J, Tuomilehto J, Uusitupa M, Rankinen T, Saris WH, Hansen T, Pedersen O, Astrup A, Sørensen TI, Qi L, Bray GA, Martinez-Gonzalez MA, Martinez JA, Franks PW, McCaffery JM, Lara J, Mathers JC. FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials. BMJ. 2016 Sep 20; 354:i4707. PMID: 27650503.
    View in: PubMed
  21. Morton AM, Furtado JD, Lee J, Amerine W, Davidson MH, Sacks FM. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. J Clin Lipidol. 2016 Nov - Dec; 10(6):1442-1451.e4. PMID: 27919362.
    View in: PubMed
  22. Heianza Y, Ma W, Huang T, Wang T, Zheng Y, Smith SR, Bray GA, Sacks FM, Qi L. Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial. Diabetes Care. 2016 Nov; 39(11):1909-1914. PMID: 27581055.
    View in: PubMed
  23. Zheng Y, Ceglarek U, Huang T, Wang T, Heianza Y, Ma W, Bray GA, Thiery J, Sacks FM, Qi L. Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. J Clin Endocrinol Metab. 2016 Oct; 101(10):3820-3826. PMID: 27466884.
    View in: PubMed
  24. Ma W, Huang T, Wang M, Zheng Y, Wang T, Heianza Y, Sun D, Smith SR, Bray GA, Sacks FM, Qi L. Two-year changes in circulating adiponectin, ectopic fat distribution and body composition in response to weight-loss diets: the POUNDS Lost Trial. Int J Obes (Lond). 2016 Nov; 40(11):1723-1729. PMID: 27460602.
    View in: PubMed
  25. Elijovich F, Weinberger MH, Anderson CA, Appel LJ, Bursztyn M, Cook NR, Dart RA, Newton-Cheh CH, Sacks FM, Laffer CL. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. 2016 Sep; 68(3):e7-e46. PMID: 27443572.
    View in: PubMed
  26. Vadiveloo M, Sacks FM, Champagne CM, Bray GA, Mattei J. Greater Healthful Dietary Variety Is Associated with Greater 2-Year Changes in Weight and Adiposity in the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial. J Nutr. 2016 Aug; 146(8):1552-9. PMID: 27358422; PMCID: PMC4958287 [Available on 08/01/17].
  27. Huang T, Ley SH, Zheng Y, Wang T, Bray GA, Sacks FM, Qi L. Genetic susceptibility to diabetes and long-term improvement of insulin resistance and ß cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Am J Clin Nutr. 2016 Jul; 104(1):198-204. PMID: 27281308; PMCID: PMC4919524 [Available on 07/01/17].
  28. Juraschek SP, McAdams-Demarco M, Gelber AC, Sacks FM, Appel LJ, White KJ, Miller ER. Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial. Arthritis Rheumatol. 2016 May; 68(5):1281-9. PMID: 26636424.
    View in: PubMed
  29. Ma W, Huang T, Zheng Y, Wang M, Bray GA, Sacks FM, Qi L. Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial. J Clin Endocrinol Metab. 2016 Jun; 101(6):2415-22. PMID: 27055193; PMCID: PMC4891796 [Available on 06/01/17].
  30. Wang T, Huang T, Zheng Y, Rood J, Bray GA, Sacks FM, Qi L. Genetic variation of fasting glucose and changes in glycemia in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Int J Obes (Lond). 2016 Jul; 40(7):1164-9. PMID: 27113490; PMCID: PMC4935586 [Available on 09/22/16].
  31. Singh SA, Andraski AB, Pieper B, Goh W, Mendivil CO, Sacks FM, Aikawa M. Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring. J Lipid Res. 2016 Apr; 57(4):714-28. PMID: 26862155; PMCID: PMC4808760 [Available on 04/01/17].
  32. Zheng Y, Ceglarek U, Huang T, Li L, Rood J, Ryan DH, Bray GA, Sacks FM, Schwarzfuchs D, Thiery J, Shai I, Qi L. Weight-loss diets and 2-y changes in circulating amino acids in 2 randomized intervention trials. Am J Clin Nutr. 2016 Feb; 103(2):505-11. PMID: 26791187; PMCID: PMC4733257 [Available on 02/01/17].
  33. Fretts AM, Mozaffarian D, Siscovick DS, King IB, McKnight B, Psaty BM, Rimm EB, Sitlani C, Sacks FM, Song X, Sotoodehnia N, Spiegelman D, Lemaitre RN. Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length. J Nutr. 2016 Feb; 146(2):298-305. PMID: 26701797; PMCID: PMC4870839 [Available on 02/01/17].
  34. Mendivil CO, Furtado J, Morton AM, Wang L, Sacks FM. Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans. Arterioscler Thromb Vasc Biol. 2016 Jan; 36(1):156-65. PMID: 26543096; PMCID: PMC4690755 [Available on 01/01/17].
  35. Brown WV, Sacks FM, Sniderman AD. JCL roundtable: Apolipoproteins as causative elements in vascular disease. J Clin Lipidol. 2015 Nov-Dec; 9(6):733-740. PMID: 26687693.
    View in: PubMed
  36. Qi Q, Zheng Y, Huang T, Rood J, Bray GA, Sacks FM, Qi L. Vitamin D metabolism-related genetic variants, dietary protein intake and improvement of insulin resistance in a 2 year weight-loss trial: POUNDS Lost. Diabetologia. 2015 Dec; 58(12):2791-9. PMID: 26416604; PMCID: PMC4631625 [Available on 12/01/16].
  37. Lin X, Qi Q, Zheng Y, Huang T, Lathrop M, Zelenika D, Bray GA, Sacks FM, Liang L, Qi L. Neuropeptide Y genotype, central obesity, and abdominal fat distribution: the POUNDS LOST trial. Am J Clin Nutr. 2015 Aug; 102(2):514-9. PMID: 26156739; PMCID: PMC4515864 [Available on 08/01/16].
  38. Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, Aggarwal NT. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015 Sep; 11(9):1015-22. PMID: 26086182; PMCID: PMC4581900.
  39. Desai NK, Ooi EM, Mitchell PD, Furtado J, Sacks FM. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. Atherosclerosis. 2015 Aug; 241(2):326-33. PMID: 26071654; PMCID: PMC4509984.
  40. Wyler von Ballmoos MC, Haring B, Sacks FM. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis. J Clin Lipidol. 2015 Jul-Aug; 9(4):498-510. PMID: 26228667.
    View in: PubMed
  41. Xu M, Ng SS, Bray GA, Ryan DH, Sacks FM, Ning G, Qi L. Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial. J Nutr. 2015 Jun; 145(6):1289-94. PMID: 25926410; PMCID: PMC4442119 [Available on 06/01/16].
  42. Sacks FM, Appel LJ, Carey VJ. Low vs high glycemic index diet--reply. JAMA. 2015 Apr 07; 313(13):1372-3. PMID: 25849187.
    View in: PubMed
  43. Tirosh A, de Souza RJ, Sacks F, Bray GA, Smith SR, LeBoff MS. Sex Differences in the Effects of Weight Loss Diets on Bone Mineral Density and Body Composition: POUNDS LOST Trial. J Clin Endocrinol Metab. 2015 Jun; 100(6):2463-71. PMID: 25825948; PMCID: PMC4454797 [Available on 06/01/16].
  44. Zheng Y, Huang T, Zhang X, Rood J, Bray GA, Sacks FM, Qi L. Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity. J Nutr. 2015 May; 145(5):977-82. PMID: 25761503; PMCID: PMC4408741 [Available on 05/01/16].
  45. Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield M, Devlin JJ, Nordio F, Hyde C, Cannon CP, Sacks F, Poulter N, Sever P, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015 Jun 06; 385(9984):2264-2271. PMID: 25748612; PMCID: PMC4608367.
  46. Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimers Dement. 2015 Sep; 11(9):1007-14. PMID: 25681666; PMCID: PMC4532650 [Available on 09/01/16].
  47. Sacks FM. The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia. Curr Opin Lipidol. 2015 Feb; 26(1):56-63. PMID: 25551803; PMCID: PMC4371603.
  48. Jensen MK, Sacks FM. Editorial. Curr Opin Lipidol. 2015 Feb; 26(1):1-2. PMID: 25551796.
    View in: PubMed
  49. Qi Q, Durst R, Schwarzfuchs D, Leitersdorf E, Shpitzen S, Li Y, Wu H, Champagne CM, Hu FB, Stampfer MJ, Bray GA, Sacks FM, Shai I, Qi L. CETP genotype and changes in lipid levels in response to weight-loss diet intervention in the POUNDS LOST and DIRECT randomized trials. J Lipid Res. 2015 Mar; 56(3):713-21. PMID: 25548261; PMCID: PMC4340318 [Available on 03/01/16].
  50. Thomas DM, Ivanescu AE, Martin CK, Heymsfield SB, Marshall K, Bodrato VE, Williamson DA, Anton SD, Sacks FM, Ryan D, Bray GA. Predicting successful long-term weight loss from short-term weight-loss outcomes: new insights from a dynamic energy balance model (the POUNDS Lost study). Am J Clin Nutr. 2015 Mar; 101(3):449-54. PMID: 25733628; PMCID: PMC4340057 [Available on 03/01/16].
  51. Wang L, Sacks FM, Furtado JD, Ricks M, Courville AB, Sumner AE. Racial differences between African-American and white women in insulin resistance and visceral adiposity are associated with differences in apoCIII containing apoAI and apoB lipoproteins. Nutr Metab (Lond). 2014; 11(1):56. PMID: 25553059; PMCID: PMC4280695.
  52. Sacks FM, Carey VJ, Anderson CA, Miller ER, Copeland T, Charleston J, Harshfield BJ, Laranjo N, McCarron P, Swain J, White K, Yee K, Appel LJ. Effects of high vs low glycemic index of dietary carbohydrate on cardiovascular disease risk factors and insulin sensitivity: the OmniCarb randomized clinical trial. JAMA. 2014 Dec 17; 312(23):2531-41. PMID: 25514303; PMCID: PMC4370345.
  53. Haring B, von Ballmoos MC, Appel LJ, Sacks FM. Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. PLoS One. 2014; 9(12):e114859. PMID: 25506933; PMCID: PMC4266632.
  54. Huang T, Huang J, Qi Q, Li Y, Bray GA, Rood J, Sacks FM, Qi L. PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: the POUNDS LOST trial. Diabetes Care. 2015 Mar; 38(3):439-44. PMID: 25504030; PMCID: PMC4876697.
  55. Willett WC, Stampfer MJ, Sacks FM. Association of dietary, circulating, and supplement fatty acids with coronary risk. Ann Intern Med. 2014 Sep 16; 161(6):453. PMID: 25222393.
    View in: PubMed
  56. Sacks FM, Stanesa M, Hegele RA. Progression to hepatitis and fibrosis secondary to lomitapide use--reply. JAMA Intern Med. 2014 Sep; 174(9):1522-3. PMID: 25178869.
    View in: PubMed
  57. McCausland F, Sacks F, Forman J. Reply: marriage and nocturnal blood pressure: a complex relationship. J Hypertens. 2014 Aug; 32(8):1722. PMID: 24991798.
    View in: PubMed
  58. Fretts AM, Mozaffarian D, Siscovick DS, Djousse L, Heckbert SR, King IB, McKnight B, Sitlani C, Sacks FM, Song X, Sotoodehnia N, Spiegelman D, Wallace ER, Lemaitre RN. Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. J Am Heart Assoc. 2014 Jun 26; 3(3):e000889. PMID: 24970268; PMCID: PMC4309088.
  59. Talayero B, Wang L, Furtado J, Carey VJ, Bray GA, Sacks FM. Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease. J Lipid Res. 2014 Oct; 55(10):2167-77. PMID: 24966274; PMCID: PMC4174008.
  60. Sacks FM, Brewer HB. Petar Alaupovic: The father of lipoprotein classification based on apolipoprotein composition. Arterioscler Thromb Vasc Biol. 2014 Jun; 34(6):1111-3. PMID: 24945028.
    View in: PubMed
  61. Postmus I, Johnson PC, Trompet S, de Craen AJ, Slagboom PE, Devlin JJ, Shiffman D, Sacks FM, Kearney PM, Stott DJ, Buckley BM, Sattar N, Ford I, Westendorp RG, Jukema JW. In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study. Atherosclerosis. 2014 Jul; 235(1):58-64. PMID: 24816038.
    View in: PubMed
  62. Ha V, Sievenpiper JL, de Souza RJ, Jayalath VH, Mirrahimi A, Agarwal A, Chiavaroli L, Mejia SB, Sacks FM, Di Buono M, Bernstein AM, Leiter LA, Kris-Etherton PM, Vuksan V, Bazinet RP, Josse RG, Beyene J, Kendall CW, Jenkins DJ. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: a systematic review and meta-analysis of randomized controlled trials. CMAJ. 2014 May 13; 186(8):E252-62. PMID: 24710915; PMCID: PMC4016088.
  63. Miyazaki T, Chiuve S, Sacks FM, Ridker PM, Libby P, Aikawa M. Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial. PLoS One. 2014; 9(4):e94073. PMID: 24705587; PMCID: PMC3976379.
  64. Causland FR, Sacks FM, Forman JP. Marital status, dipping and nocturnal blood pressure: results from the Dietary Approaches to Stop Hypertension trial. J Hypertens. 2014 Apr; 32(4):756-61. PMID: 24509120.
    View in: PubMed
  65. Huang T, Qi Q, Li Y, Hu FB, Bray GA, Sacks FM, Williamson DA, Qi L. FTO genotype, dietary protein, and change in appetite: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2014 May; 99(5):1126-30. PMID: 24622803; PMCID: PMC3985215.
  66. Sacks FM, Stanesa M, Hegele RA. Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide. JAMA Intern Med. 2014 Mar; 174(3):443-7. PMID: 24366202.
    View in: PubMed
  67. Barte JC, Veldwijk J, Teixeira PJ, Sacks FM, Bemelmans WJ. Differences in weight loss across different BMI classes: a meta-analysis of the effects of interventions with diet and exercise. Int J Behav Med. 2014; 21(5):784-93. PMID: 24797705.
    View in: PubMed
  68. Sumner AE, Furtado JD, Courville AB, Ricks M, Younger-Coleman N, Tulloch-Reid MK, Sacks FM. ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women. Nutr Metab (Lond). 2013 Dec 23; 10(1):73. PMID: 24365086; PMCID: PMC3878037.
  69. Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E, Wanner C, Al-Rubeaan K, Aronson R, Barzon I, Bishop L, Bonora E, Bunnag P, Chuang LM, Deerochanawong C, Goldenberg R, Harshfield B, Hernández C, Herzlinger-Botein S, Itoh H, Jia W, Jiang YD, Kadowaki T, Laranjo N, Leiter L, Miwa T, Odawara M, Ohashi K, Ohno A, Pan C, Pan J, Pedro-Botet J, Reiner Z, Rotella CM, Simo R, Tanaka M, Tedeschi-Reiner E, Twum-Barima D, Zoppini G, Carey VJ. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation. 2014 Mar 04; 129(9):999-1008. PMID: 24352521.
    View in: PubMed
  70. Mirzaei K, Xu M, Qi Q, de Jonge L, Bray GA, Sacks F, Qi L. Variants in glucose- and circadian rhythm-related genes affect the response of energy expenditure to weight-loss diets: the POUNDS LOST Trial. Am J Clin Nutr. 2014 Feb; 99(2):392-9. PMID: 24335056; PMCID: PMC3893729.
  71. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC, Svetkey LP, Wadden TA, Yanovski SZ. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Jul 01; 63(25 Pt B):2960-84. PMID: 24239922.
    View in: PubMed
  72. Eckel RH, Jakicic JM, Ard JD, de Jesus JM, Houston Miller N, Hubbard VS, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Nonas CA, Sacks FM, Smith SC, Svetkey LP, Wadden TA, Yanovski SZ, Kendall KA, Morgan LC, Trisolini MG, Velasco G, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S76-99. PMID: 24222015.
    View in: PubMed
  73. O'Donoghue ML, Morrow DA, Tsimikas S, Sloan S, Ren AF, Hoffman EB, Desai NR, Solomon SD, Domanski M, Arai K, Chiuve SE, Cannon CP, Sacks FM, Sabatine MS. Lipoprotein(a) for risk assessment in patients with established coronary artery disease. J Am Coll Cardiol. 2014 Feb 18; 63(6):520-7. PMID: 24161323; PMCID: PMC3945105.
  74. Qi Q, Xu M, Wu H, Liang L, Champagne CM, Bray GA, Sacks FM, Qi L. IRS1 genotype modulates metabolic syndrome reversion in response to 2-year weight-loss diet intervention: the POUNDS LOST trial. Diabetes Care. 2013 Nov; 36(11):3442-7. PMID: 24009303; PMCID: PMC3816909.
  75. Mendivil CO, Rimm EB, Furtado J, Sacks FM. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease. J Am Heart Assoc. 2013 May 14; 2(3):e000130. PMID: 23672999; PMCID: PMC3698772.
  76. Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS. Plasma phospholipid long-chain ?-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med. 2013 Apr 02; 158(7):515-25. PMID: 23546563; PMCID: PMC3698844.
  77. Nicklas JM, Sacks FM, Smith SR, LeBoff MS, Rood JC, Bray GA, Ridker PM. Effect of dietary composition of weight loss diets on high-sensitivity c-reactive protein: the Randomized POUNDS LOST trial. Obesity (Silver Spring). 2013 Apr; 21(4):681-9. PMID: 23712970; PMCID: PMC3671388.
  78. Mc Causland FR, McMullan CJ, Sacks FM, Forman JP. Race, plasma renin activity, and morning blood pressure surge--results from the Dietary Approaches to Stop Hypertension trial. Am J Hypertens. 2014 Apr; 27(4):530-6. PMID: 23475701; PMCID: PMC4014854.
  79. Xu M, Qi Q, Liang J, Bray GA, Hu FB, Sacks FM, Qi L. Genetic determinant for amino acid metabolites and changes in body weight and insulin resistance in response to weight-loss diets: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 2013 Mar 26; 127(12):1283-9. PMID: 23446828; PMCID: PMC3860590.
  80. Fretts AM, Mozaffarian D, Siscovick DS, Heckbert SR, McKnight B, King IB, Rimm EB, Psaty BM, Sacks FM, Song X, Spiegelman D, Lemaitre RN. Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study. J Am Heart Assoc. 2013 Jan 31; 2(1):e003814. PMID: 23525429; PMCID: PMC3603242.
  81. Gadgil MD, Appel LJ, Yeung E, Anderson CA, Sacks FM, Miller ER. The effects of carbohydrate, unsaturated fat, and protein intake on measures of insulin sensitivity: results from the OmniHeart trial. Diabetes Care. 2013 May; 36(5):1132-7. PMID: 23223345; PMCID: PMC3631872.
  82. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012 Dec 11; 126(24):2880-9. PMID: 23124030.
    View in: PubMed
  83. Mattei J, Qi Q, Hu FB, Sacks FM, Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr. 2012 Nov; 96(5):1129-36. PMID: 23034957; PMCID: PMC3471200.
  84. Zhang X, Qi Q, Liang J, Hu FB, Sacks FM, Qi L. Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial. Hypertension. 2012 Nov; 60(5):1169-75. PMID: 22966009; PMCID: PMC3869086.
  85. Berglund L, Brunzell J, Sacks FM. Patient information page from The Hormone Foundations. Patient guide to the assessment and treatment of hypertriglyceridemia (high triglycerides). J Clin Endocrinol Metab. 2012 Sep; 97(9):31A-32A. PMID: 22962678.
    View in: PubMed
  86. Anton SD, LeBlanc E, Allen HR, Karabetian C, Sacks F, Bray G, Williamson DA. Use of a computerized tracking system to monitor and provide feedback on dietary goals for calorie-restricted diets: the POUNDS LOST study. J Diabetes Sci Technol. 2012 Sep 01; 6(5):1216-25. PMID: 23063049; PMCID: PMC3570857.
  87. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Sep; 97(9):2969-89. PMID: 22962670; PMCID: PMC3431581.
  88. Zheng C, Azcutia V, Aikawa E, Figueiredo JL, Croce K, Sonoki H, Sacks FM, Luscinskas FW, Aikawa M. Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion. Eur Heart J. 2013 Feb; 34(8):615-24. PMID: 22927557; PMCID: PMC3578265.
  89. Zhang X, Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial. Am J Clin Nutr. 2012 Oct; 96(4):917-22. PMID: 22914552; PMCID: PMC3441115.
  90. Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes. 2012 Nov; 61(11):3005-11. PMID: 22891219; PMCID: PMC3478519.
  91. Lemaitre RN, Sitlani C, Song X, King IB, McKnight B, Spiegelman D, Sacks FM, Djoussé L, Rimm EB, Siscovick DS, Mozaffarian D. Circulating and dietary a-linolenic acid and incidence of congestive heart failure in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2012 Aug; 96(2):269-74. PMID: 22743310; PMCID: PMC3396442.
  92. Anton SD, Gallagher J, Carey VJ, Laranjo N, Cheng J, Champagne CM, Ryan DH, McManus K, Loria CM, Bray GA, Sacks FM, Williamson DA. Diet type and changes in food cravings following weight loss: findings from the POUNDS LOST Trial. Eat Weight Disord. 2012 Jun; 17(2):e101-8. PMID: 23010779; PMCID: PMC4189179.
  93. Shiffman D, Trompet S, Louie JZ, Rowland CM, Catanese JJ, Iakoubova OA, Kirchgessner TG, Westendorp RG, de Craen AJ, Slagboom PE, Buckley BM, Stott DJ, Sattar N, Devlin JJ, Packard CJ, Ford I, Sacks FM, Jukema JW. Genome-wide study of gene variants associated with differential cardiovascular event reduction by pravastatin therapy. PLoS One. 2012; 7(5):e38240. PMID: 22666496; PMCID: PMC3364212.
  94. de Jonge L, Bray GA, Smith SR, Ryan DH, de Souza RJ, Loria CM, Champagne CM, Williamson DA, Sacks FM. Effect of diet composition and weight loss on resting energy expenditure in the POUNDS LOST study. Obesity (Silver Spring). 2012 Dec; 20(12):2384-9. PMID: 22627912; PMCID: PMC3760199.
  95. Jensen MK, Rimm EB, Furtado JD, Sacks FM. Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease. J Am Heart Assoc. 2012 Apr; 1(2). PMID: 23130121; PMCID: PMC3487368.
  96. Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, Sudhakar R, Sagar A, Wang Y, Sacks F, Afonso L. Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction. Am J Cardiol. 2012 Jun 15; 109(12):1694-9. PMID: 22465317.
    View in: PubMed
  97. Furtado JD, Wedel MK, Sacks FM. Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins. J Lipid Res. 2012 Apr; 53(4):784-91. PMID: 22301884; PMCID: PMC3307655.
  98. Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D. Association of plasma phospholipid long-chain ?-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation. 2012 Mar 06; 125(9):1084-93. PMID: 22282329; PMCID: PMC3302663.
  99. de Souza RJ, Bray GA, Carey VJ, Hall KD, LeBoff MS, Loria CM, Laranjo NM, Sacks FM, Smith SR. Effects of 4 weight-loss diets differing in fat, protein, and carbohydrate on fat mass, lean mass, visceral adipose tissue, and hepatic fat: results from the POUNDS LOST trial. Am J Clin Nutr. 2012 Mar; 95(3):614-25. PMID: 22258266; PMCID: PMC3278241.
  100. Qi Q, Bray GA, Hu FB, Sacks FM, Qi L. Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial. Am J Clin Nutr. 2012 Feb; 95(2):506-13. PMID: 22237064; PMCID: PMC3260076.
  101. Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011 Dec; 13(6):544-52. PMID: 21968696; PMCID: PMC3234107.
  102. Mendivil CO, Rimm EB, Furtado J, Chiuve SE, Sacks FM. Low-density lipoproteins containing apolipoprotein C-III and the risk of coronary heart disease. Circulation. 2011 Nov 08; 124(19):2065-72. PMID: 21986282; PMCID: PMC3244212.
  103. Trompet S, de Craen AJ, Postmus I, Ford I, Sattar N, Caslake M, Stott DJ, Buckley BM, Sacks F, Devlin JJ, Slagboom PE, Westendorp RG, Jukema JW. Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses. BMC Med Genet. 2011 Oct 06; 12:131. PMID: 21977987; PMCID: PMC3207930.
  104. Bray GA, Smith SR, DeJonge L, de Souza R, Rood J, Champagne CM, Laranjo N, Carey V, Obarzanek E, Loria CM, Anton SD, Ryan DH, Greenway FL, Williamson D, Sacks FM. Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study. Int J Obes (Lond). 2012 Mar; 36(3):448-55. PMID: 21946707; PMCID: PMC3289771.
  105. Mozaffarian D, Lemaitre RN, King IB, Song X, Spiegelman D, Sacks FM, Rimm EB, Siscovick DS. Circulating long-chain ?-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. Ann Intern Med. 2011 Aug 02; 155(3):160-70. PMID: 21810709; PMCID: PMC3371768.
  106. Qi Q, Bray GA, Smith SR, Hu FB, Sacks FM, Qi L. Insulin receptor substrate 1 gene variation modifies insulin resistance response to weight-loss diets in a 2-year randomized trial: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial. Circulation. 2011 Aug 02; 124(5):563-71. PMID: 21747052; PMCID: PMC3171189.
  107. Braunwald E, Sacks FM, Pfeffer MA, Ridker PM. HMG CoA reduction in patients with average cholesterol concentrations. Clin Chem. 2011 Jul; 57(7):1072-3. PMID: 21519035.
    View in: PubMed
  108. Sacks FM, Zheng C, Cohn JS. Complexities of plasma apolipoprotein C-III metabolism. J Lipid Res. 2011 Jun; 52(6):1067-70. PMID: 21421846; PMCID: PMC3090227.
  109. Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovasc Diabetol. 2011 Feb 28; 10:20. PMID: 21356116; PMCID: PMC3056766.
  110. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-Nahas M, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K, Mann JF, Yusuf S, Teo KK, Gao P, Nelson RG, Knowler WC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011 Jun; 79(12):1341-52. PMID: 21307840.
    View in: PubMed
  111. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC, Vafiadis DK, Van Horn LV. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation. 2011 Mar 15; 123(10):1138-43. PMID: 21233236.
    View in: PubMed
  112. Millán Núñez-Cortés J, Montoya JP, Salas XP, Hernández Mijares A, Carey VJ, Hermans MP, Sacks FM, Fruchart JC. [The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: an analysis of residual risk attributable to lipid profile in acute coronary syndrome]. Endocrinol Nutr. 2011 Jan; 58(1):38-47. PMID: 21208833.
    View in: PubMed
  113. Bare LA, Ruiz-Narvaéz EA, Tong CH, Arellano AR, Rowland CM, Catanese JJ, Sacks FM, Devlin JJ, Campos H. Investigation of KIF6 Trp719Arg in a case-control study of myocardial infarction: a Costa Rican population. PLoS One. 2010 Sep 29; 5(9). PMID: 20927332; PMCID: PMC2947524.
  114. Abe Y, Kawakami A, Osaka M, Uematsu S, Akira S, Shimokado K, Sacks FM, Yoshida M. Apolipoprotein CIII induces monocyte chemoattractant protein-1 and interleukin 6 expression via Toll-like receptor 2 pathway in mouse adipocytes. Arterioscler Thromb Vasc Biol. 2010 Nov; 30(11):2242-8. PMID: 20829510; PMCID: PMC3203842.
  115. Furtado JD, Campos H, Sumner AE, Appel LJ, Carey VJ, Sacks FM. Dietary interventions that lower lipoproteins containing apolipoprotein C-III are more effective in whites than in blacks: results of the OmniHeart trial. Am J Clin Nutr. 2010 Oct; 92(4):714-22. PMID: 20826623; PMCID: PMC2937582.
  116. Sacks FM, Carey VJ, Fruchart JC. Combination lipid therapy in type 2 diabetes. N Engl J Med. 2010 Aug 12; 363(7):692-4; author reply 694-5. PMID: 20842772.
    View in: PubMed
  117. Carey VJ, Bishop L, Laranjo N, Harshfield BJ, Kwiat C, Sacks FM. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control. Am J Cardiol. 2010 Sep 15; 106(6):757-63. PMID: 20816113; PMCID: PMC4102341.
  118. Fruchart JC, Sacks FM, Hermans MP. Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Curr Med Res Opin. 2010 Aug; 26(8):1793-7. PMID: 20482323.
    View in: PubMed
  119. Sacks FM, Campos H. Dietary therapy in hypertension. N Engl J Med. 2010 Jun 03; 362(22):2102-12. PMID: 20519681.
    View in: PubMed
  120. Cook NR, Sacks F, MacGregor G. Public policy and dietary sodium restriction. JAMA. 2010 May 19; 303(19):1917; author reply 1917-8. PMID: 20483966.
    View in: PubMed
  121. Zheng C, Khoo C, Furtado J, Sacks FM. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation. 2010 Apr 20; 121(15):1722-34. PMID: 20368524; PMCID: PMC3153990.
  122. Shiffman D, Sabatine MS, Louie JZ, Kirchgessner TG, Iakoubova OA, Campos H, Devlin JJ, Sacks FM. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. Am J Cardiol. 2010 May 01; 105(9):1300-5. PMID: 20403483.
    View in: PubMed
  123. Micha R, King IB, Lemaitre RN, Rimm EB, Sacks F, Song X, Siscovick DS, Mozaffarian D. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. Am J Clin Nutr. 2010 Apr; 91(4):883-93. PMID: 20219966; PMCID: PMC2844676.
  124. Williamson DA, Anton SD, Han H, Champagne CM, Allen R, Leblanc E, Ryan DH, Rood J, McManus K, Laranjo N, Carey VJ, Loria CM, Bray GA, Sacks FM. Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study. J Behav Med. 2010 Aug; 33(4):305-14. PMID: 20195742; PMCID: PMC3150109.
  125. Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):239-45. PMID: 19910636; PMCID: PMC2818784.
  126. Williamson DA, Anton SD, Han H, Champagne CM, Allen R, LeBlanc E, Ryan DH, McManus K, Laranjo N, Carey VJ, Loria CM, Bray GA, Sacks FM. Adherence is a multi-dimensional construct in the POUNDS LOST trial. J Behav Med. 2010 Feb; 33(1):35-46. PMID: 19856202; PMCID: PMC3153914.
  127. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation. 2009 Nov 03; 120(18):1784-92. PMID: 19841303.
    View in: PubMed
  128. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009 Sep 15; 120(11):1011-20. PMID: 19704096.
    View in: PubMed
  129. Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009 Feb 26; 360(9):859-73. PMID: 19246357; PMCID: PMC2763382.
  130. Beasley JM, Ange BA, Anderson CA, Miller ER, Erlinger TP, Holbrook JT, Sacks FM, Appel LJ. Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart Disease. Am J Epidemiol. 2009 Apr 01; 169(7):893-900. PMID: 19224977; PMCID: PMC2727221.
  131. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009 Feb 17; 119(6):902-7. PMID: 19171857.
    View in: PubMed
  132. Jacobs DR, Gross MD, Steffen L, Steffes MW, Yu X, Svetkey LP, Appel LJ, Vollmer WM, Bray GA, Moore T, Conlin PR, Sacks F. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Kidney Dis. 2009 Apr; 53(4):638-46. PMID: 19167797; PMCID: PMC2676223.
  133. Sacks FM, Rudel LL, Conner A, Akeefe H, Kostner G, Baki T, Rothblat G, de la Llera-Moya M, Asztalos B, Perlman T, Zheng C, Alaupovic P, Maltais JA, Brewer HB. Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. J Lipid Res. 2009 May; 50(5):894-907. PMID: 19144994; PMCID: PMC2666176.
  134. Sacks FM. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction. Am J Cardiol. 2008 Dec 22; 102(12A):1L-3L. PMID: 19084082.
    View in: PubMed
  135. Sacks FM. After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: implications for fenofibrate. Am J Cardiol. 2008 Dec 22; 102(12A):34L-40L. PMID: 19084088.
    View in: PubMed
  136. Pfeffer MA, Sacks FM. Leapfrogging data: no shortcuts for safety or efficacy information. Circulation. 2008 Dec 09; 118(24):2491-4. PMID: 19064690.
    View in: PubMed
  137. Fruchart JC, Sacks F, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol. 2008 Nov 17; 102(10 Suppl):1K-34K. PMID: 19068318.
    View in: PubMed
  138. Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, Chapman MJ, Dodson PM, Fioretto P, Ginsberg HN, Kadowaki T, Lablanche JM, Marx N, Plutzky J, Reiner Z, Rosenson RS, Staels B, Stock JK, Sy R, Wanner C, Zambon A, Zimmet P. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient. Diab Vasc Dis Res. 2008 Nov; 5(4):319-35. PMID: 18958843.
    View in: PubMed
  139. Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K, Sacks FM, Yoshida M. Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ Res. 2008 Dec 05; 103(12):1402-9. PMID: 18974386; PMCID: PMC2994199.
  140. Zheng C, Khoo C, Furtado J, Ikewaki K, Sacks FM. Dietary monounsaturated fat activates metabolic pathways for triglyceride-rich lipoproteins that involve apolipoproteins E and C-III. Am J Clin Nutr. 2008 Aug; 88(2):272-81. PMID: 18689361; PMCID: PMC2547880.
  141. Sacks FM. Major potential of diet treatment for type 2 diabetes. Curr Diab Rep. 2008 Aug; 8(4):249-50. PMID: 18631434.
    View in: PubMed
  142. Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K, Yoshida M. Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction. Circulation. 2008 Aug 12; 118(7):731-42. PMID: 18663085.
    View in: PubMed
  143. de Souza RJ, Swain JF, Appel LJ, Sacks FM. Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations. Am J Clin Nutr. 2008 Jul; 88(1):1-11. PMID: 18614716; PMCID: PMC2674146.
  144. Iakoubova O, Shepherd J, Sacks F. Association of the 719Arg variant of KIF6 with both increased risk of coronary events and with greater response to statin therapy. J Am Coll Cardiol. 2008 Jun 03; 51(22):2195; author reply 2195-6. PMID: 18510970.
    View in: PubMed
  145. Ruiz-Narváez EA, Sacks FM, Campos H. Abdominal obesity and hyperglycemia mask the effect of a common APOC3 haplotype on the risk of myocardial infarction. Am J Clin Nutr. 2008 Jun; 87(6):1932-8. PMID: 18541587; PMCID: PMC3861874.
  146. Furtado JD, Campos H, Appel LJ, Miller ER, Laranjo N, Carey VJ, Sacks FM. Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial. Am J Clin Nutr. 2008 Jun; 87(6):1623-30. PMID: 18541549; PMCID: PMC2494528.
  147. Swain JF, McCarron PB, Hamilton EF, Sacks FM, Appel LJ. Characteristics of the diet patterns tested in the optimal macronutrient intake trial to prevent heart disease (OmniHeart): options for a heart-healthy diet. J Am Diet Assoc. 2008 Feb; 108(2):257-65. PMID: 18237574; PMCID: PMC3236092.
  148. Iakoubova OA, Tong CH, Rowland CM, Kirchgessner TG, Young BA, Arellano AR, Shiffman D, Sabatine MS, Campos H, Packard CJ, Pfeffer MA, White TJ, Braunwald E, Shepherd J, Devlin JJ, Sacks FM. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008 Jan 29; 51(4):435-43. PMID: 18222353.
    View in: PubMed
  149. Sabatine MS, Ploughman L, Simonsen KL, Iakoubova OA, Kirchgessner TG, Ranade K, Tsuchihashi Z, Zerba KE, Long DU, Tong CH, Packard CJ, Pfeffer MA, Devlin JJ, Shepherd J, Campos H, Sacks FM, Braunwald E. Association between ADAMTS1 matrix metalloproteinase gene variation, coronary heart disease, and benefit of statin therapy. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):562-7. PMID: 18174457.
    View in: PubMed
  150. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation Between Red Blood Cell Distribution Width and Cardiovascular Event Rate in People With Coronary Disease. Circulation. 2008 Jan 15; 117(2):163-168. PMID: 18172029.
    View in: PubMed
  151. Karanja N, Lancaster KJ, Vollmer WM, Lin PH, Most MM, Ard JD, Swain JF, Sacks FM, Obarzanek E. Acceptability of sodium-reduced research diets, including the Dietary Approaches To Stop Hypertension diet, among adults with prehypertension and stage 1 hypertension. J Am Diet Assoc. 2007 Sep; 107(9):1530-8. PMID: 17761230; PMCID: PMC3219218.
  152. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007 Jul 18; 298(3):309-16. PMID: 17635891.
    View in: PubMed
  153. Bier DM, Abrams SA, Bowman BA, Fukagawa NK, Gitlin JD, Klurfeld DM, Sacks FM. Conflict of interest policy for Editors of The American Journal of Clinical Nutrition. Am J Clin Nutr. 2007 Jul; 86(1):3-4. PMID: 17616755.
    View in: PubMed
  154. Matsuzawa Y, Kita T, Shepherd J, Gotto AM, Nakamura H, Sacks FM, Oikawa S, Sasaki J. A trilogy of primary prevention statin trials. Panel discussion. Atheroscler Suppl. 2007 Aug; 8(2):19-24. PMID: 17588827.
    View in: PubMed
  155. Zheng C, Khoo C, Ikewaki K, Sacks FM. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions. J Lipid Res. 2007 May; 48(5):1190-203. PMID: 17314277.
    View in: PubMed
  156. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol. 2007 Jan; 27(1):219-25. PMID: 17038637.
    View in: PubMed
  157. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol. 2006 Oct; 26(10):2186-91. PMID: 16990564.
    View in: PubMed
  158. Iakoubova OA, Tong CH, Chokkalingam AP, Rowland CM, Kirchgessner TG, Louie JZ, Ploughman LM, Sabatine MS, Campos H, Catanese JJ, Leong DU, Young BA, Lew D, Tsuchihashi Z, Luke MM, Packard CJ, Zerba KE, Shaw PM, Shepherd J, Devlin JJ, Sacks FM. Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS. Arterioscler Thromb Vasc Biol. 2006 Dec; 26(12):2763-8. PMID: 17008591.
    View in: PubMed
  159. Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM. Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation. 2006 Aug 15; 114(7):681-7. PMID: 16894036.
    View in: PubMed
  160. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee. Arterioscler Thromb Vasc Biol. 2006 Aug; 26(8):1689-92. PMID: 16857959.
    View in: PubMed
  161. Sacks FM. The apolipoprotein story. Atheroscler Suppl. 2006 Aug; 7(4):23-7. PMID: 16822722.
    View in: PubMed
  162. Chiuve SE, McCullough ML, Sacks FM, Rimm EB. Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation. 2006 Jul 11; 114(2):160-7. PMID: 16818808.
    View in: PubMed
  163. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006 Jul 04; 114(1):82-96. PMID: 16785338.
    View in: PubMed
  164. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006 Jun 17; 332(7555):1426. PMID: 16714328; PMCID: PMC1479622.
  165. Zheng C, Ikewaki K, Walsh BW, Sacks FM. Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J Lipid Res. 2006 Aug; 47(8):1771-9. PMID: 16685082; PMCID: PMC3219222.
  166. Tonelli M, Sacks F, Pfeffer M, Lopez-Jimenez F, Jhangri GS, Curhan G. Effect of pravastatin on blood pressure in people with cardiovascular disease. J Hum Hypertens. 2006 Aug; 20(8):560-5. PMID: 16625234.
    View in: PubMed
  167. Kawakami A, Aikawa M, Libby P, Alcaide P, Luscinskas FW, Sacks FM. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells. Circulation. 2006 Feb 07; 113(5):691-700. PMID: 16461842.
    View in: PubMed
  168. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006 Feb; 47(2):296-308. PMID: 16434724.
    View in: PubMed
  169. Sacks FM, Campos H. Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. J Clin Endocrinol Metab. 2006 Feb; 91(2):398-400. PMID: 16461954.
    View in: PubMed
  170. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006 Feb 21; 113(7):1034-44. PMID: 16418439.
    View in: PubMed
  171. Zheng C, Murdoch SJ, Brunzell JD, Sacks FM. Lipoprotein lipase bound to apolipoprotein B lipoproteins accelerates clearance of postprandial lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006 Apr; 26(4):891-6. PMID: 16410459; PMCID: PMC3219220.
  172. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005 Nov 29; 112(22):3375-83. PMID: 16316964.
    View in: PubMed
  173. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER, Conlin PR, Erlinger TP, Rosner BA, Laranjo NM, Charleston J, McCarron P, Bishop LM. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA. 2005 Nov 16; 294(19):2455-64. PMID: 16287956.
    View in: PubMed
  174. Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, Pfeffer M, Simes J, Isles C, Furberg C, West M, Craven T, Curhan G. Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol. 2005 Dec; 16(12):3748-54. PMID: 16251235.
    View in: PubMed
  175. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005 Oct 25; 112(17):2627-33. PMID: 16246962.
    View in: PubMed
  176. Ranade K, Kirchgessner TG, Iakoubova OA, Devlin JJ, DelMonte T, Vishnupad P, Hui L, Tsuchihashi Z, Sacks FM, Sabatine MS, Braunwald E, White TJ, Shaw PM, Dracopoli NC. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke. 2005 Nov; 36(11):2346-50. PMID: 16239632.
    View in: PubMed
  177. Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol. 2005 Oct 18; 46(8):1405-10. PMID: 16226162.
    View in: PubMed
  178. van den Elzen P, Garg S, León L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA, Besra GS, Kent SC, Moody DB, Brenner MB. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature. 2005 Oct 06; 437(7060):906-10. PMID: 16208376.
    View in: PubMed
  179. Tonelli M, Isles C, Craven T, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, West M, Packard C, Curhan GC. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease. Circulation. 2005 Jul 12; 112(2):171-8. PMID: 15998677.
    View in: PubMed
  180. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005 Jul; 68(1):237-45. PMID: 15954913.
    View in: PubMed
  181. Miller ER, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin PH, Appel LJ. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis. 2005 Nov; 183(1):175-82. PMID: 16216596.
    View in: PubMed
  182. Campos H, Khoo C, Sacks FM. Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis. 2005 Aug; 181(2):345-51. PMID: 16039289.
    View in: PubMed
  183. Sacks FM. Dietary phytoestrogens to prevent cardiovascular disease: early promise unfulfilled. Circulation. 2005 Feb 01; 111(4):385-7. PMID: 15687122.
    View in: PubMed
  184. Goff DC, Cather C, Evins AE, Henderson DC, Freudenreich O, Copeland PM, Bierer M, Duckworth K, Sacks FM. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry. 2005 Feb; 66(2):183-94; quiz 147, 273-4. PMID: 15705003.
    View in: PubMed
  185. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 2005 Jan 25; 111(3):278-87. PMID: 15655129.
    View in: PubMed
  186. Sacks FM, Skerrett PJ. Your health in the 21st century. Fine-tuning heart health. Newsweek. 2005; 145(26A):22-3. PMID: 16375135.
    View in: PubMed
  187. Carey VJ, Bishop L, Charleston J, Conlin P, Erlinger T, Laranjo N, McCarron P, Miller E, Rosner B, Swain J, Sacks FM, Appel LJ. Rationale and design of the Optimal Macro-Nutrient Intake Heart Trial to Prevent Heart Disease (OMNI-Heart). Clin Trials. 2005; 2(6):529-37. PMID: 16422313.
    View in: PubMed
  188. Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation. 2004 Sep 21; 110(12):1557-63. PMID: 15364796.
    View in: PubMed
  189. Byington RP, Sacks FM. Lessons learned from the prospective pravastatin pooling project. Curr Atheroscler Rep. 2004 Sep; 6(5):366-74. PMID: 15296703.
    View in: PubMed
  190. Bray GA, Vollmer WM, Sacks FM, Obarzanek E, Svetkey LP, Appel LJ. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol. 2004 Jul 15; 94(2):222-7. PMID: 15246908.
    View in: PubMed
  191. Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ. Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control. J Clin Hypertens (Greenwich). 2004 Jul; 6(7):373-81. PMID: 15249792.
    View in: PubMed
  192. Rifai N, Ma J, Sacks FM, Ridker PM, Hernandez WJ, Stampfer MJ, Marcovina SM. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study. Clin Chem. 2004 Aug; 50(8):1364-71. PMID: 15155542.
    View in: PubMed
  193. Chiuve SE, Martin LA, Campos H, Sacks FM. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. J Clin Endocrinol Metab. 2004 May; 89(5):2207-13. PMID: 15126543.
    View in: PubMed
  194. Sacks FM. High-intensity statin treatment for coronary heart disease. JAMA. 2004 Mar 03; 291(9):1132-4. PMID: 14996784.
    View in: PubMed
  195. de Grooth GJ, Zerba KE, Huang SP, Tsuchihashi Z, Kirchgessner T, Belder R, Vishnupad P, Hu B, Klerkx AH, Zwinderman AH, Jukema JW, Sacks FM, Kastelein JJ, Kuivenhoven JA. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. J Am Coll Cardiol. 2004 Mar 03; 43(5):854-7. PMID: 14998629.
    View in: PubMed
  196. Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. Arch Intern Med. 2004 Jan 12; 164(1):40-4. PMID: 14718320.
    View in: PubMed
  197. Harsha DW, Sacks FM, Obarzanek E, Svetkey LP, Lin PH, Bray GA, Aickin M, Conlin PR, Miller ER, Appel LJ. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension. 2004 Feb; 43(2):393-8. PMID: 14707154.
    View in: PubMed
  198. Sacks FM. Metabolic syndrome: epidemiology and consequences. J Clin Psychiatry. 2004; 65 Suppl 18:3-12. PMID: 15600380.
    View in: PubMed
  199. Seeger JD, Walker AM, Williams PL, Saperia GM, Sacks FM. A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol. 2003 Dec 15; 92(12):1447-51. PMID: 14675584.
    View in: PubMed
  200. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, Flaker GC, Braunwald E, Pfeffer MA. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol. 2003 Oct 15; 42(8):1446-53. PMID: 14563590.
    View in: PubMed
  201. Sacks FM, Campos H. Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab. 2003 Oct; 88(10):4525-32. PMID: 14557416.
    View in: PubMed
  202. Obarzanek E, Proschan MA, Vollmer WM, Moore TJ, Sacks FM, Appel LJ, Svetkey LP, Most-Windhauser MM, Cutler JA. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension. 2003 Oct; 42(4):459-67. PMID: 12953018.
    View in: PubMed
  203. Lee SJ, Sacks FM. Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus. Am J Cardiol. 2003 Jul 15; 92(2):121-4. PMID: 12860210.
    View in: PubMed
  204. Sacks FM, Appel LJ, Bray GA, Conlin PR, Moore TJ, Svetkey LP, Vollmer WM. Sodium and blood pressure: no data dredging, please! Am J Hypertens. 2003 Jul; 16(7):614-6. PMID: 12850399.
    View in: PubMed
  205. Tonelli M, Moyé L, Sacks FM, Cole T, Curhan GC. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003 Jun; 14(6):1605-13. PMID: 12761262.
    View in: PubMed
  206. Akita S, Sacks FM, Svetkey LP, Conlin PR, Kimura G. Effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the pressure-natriuresis relationship. Hypertension. 2003 Jul; 42(1):8-13. PMID: 12756219.
    View in: PubMed
  207. Lee SJ, Moye LA, Campos H, Williams GH, Sacks FM. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease. Atherosclerosis. 2003 Apr; 167(2):293-302. PMID: 12818412.
    View in: PubMed
  208. Lin PH, Aickin M, Champagne C, Craddick S, Sacks FM, McCarron P, Most-Windhauser MM, Rukenbrod F, Haworth L. Food group sources of nutrients in the dietary patterns of the DASH-Sodium trial. J Am Diet Assoc. 2003 Apr; 103(4):488-96. PMID: 12669013.
    View in: PubMed
  209. Lee SJ, Campos H, Moye LA, Sacks FM. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol. 2003 May 01; 23(5):853-8. PMID: 12637336.
    View in: PubMed
  210. Tonelli M, Moyé L, Sacks FM, Kiberd B, Curhan G. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med. 2003 Jan 21; 138(2):98-104. PMID: 12529091.
    View in: PubMed
  211. Sacks FM, Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med. 2002 Dec 30; 113 Suppl 9B:13S-24S. PMID: 12566134.
    View in: PubMed
  212. Sacks FM. Dietary fat, the Mediterranean diet, and health: reports from scientific exchanges, 1998 and 2000. Introduction. Am J Med. 2002 Dec 30; 113 Suppl 9B:1S-4S. PMID: 12566131.
    View in: PubMed
  213. Sacks FM. Low-density lipoprotein lowering therapy: an analysis of the options. J Am Coll Cardiol. 2002 Dec 18; 40(12):2135-8. PMID: 12505225.
    View in: PubMed
  214. Sacks FM. Adherence to statin therapy: why aren't we doing better? Am J Med. 2002 Dec 01; 113(8):685-6. PMID: 12505120.
    View in: PubMed
  215. Jehn M, Appel LJ, Sacks FM, Miller ER. The effect of ambient temperature and barometric pressure on ambulatory blood pressure variability. Am J Hypertens. 2002 Nov; 15(11):941-5. PMID: 12441212.
    View in: PubMed
  216. Sacks FM. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol. 2002 Jul 15; 90(2):139-43. PMID: 12106843.
    View in: PubMed
  217. Sacks FM, Alaupovic P, Moye LA. Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins. Am J Cardiol. 2002 Jul 15; 90(2):165-7. PMID: 12106851.
    View in: PubMed
  218. Pfeffer MA, Keech A, Sacks FM, Cobbe SM, Tonkin A, Byington RP, Davis BR, Friedman CP, Braunwald E. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation. 2002 May 21; 105(20):2341-6. PMID: 12021218.
    View in: PubMed
  219. Liu S, Schmitz C, Stampfer MJ, Sacks F, Hennekens CH, Lindpaintner K, Ridker PM, Liu S. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis. 2002 Apr; 161(2):469-74. PMID: 11888533.
    View in: PubMed
  220. Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation. 2002 Mar 26; 105(12):1424-8. PMID: 11914249.
    View in: PubMed
  221. Lin YS, Smith TJ, Wypij D, Kelsey KT, Sacks FM. Association of the blood/air partition coefficient of 1,3-butadiene with blood lipids and albumin. Environ Health Perspect. 2002 Feb; 110(2):165-8. PMID: 11836145; PMCID: PMC1240731.
  222. Sacks FM. The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials. Am J Cardiol. 2001 Dec 20; 88(12A):14N-18N. PMID: 11788125.
    View in: PubMed
  223. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med. 2001 Dec 18; 135(12):1019-28. PMID: 11747380.
    View in: PubMed
  224. Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, Kesari M. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens. 2001 Nov; 19(11):1949-56. PMID: 11677359.
    View in: PubMed
  225. Hu FB, Sacks F, Willett WC. Dietary fats and prevention of cardiovascular disease. Patient compliance should have been considered. BMJ. 2001 Oct 27; 323(7319):1001-2. PMID: 11700626.
    View in: PubMed
  226. McManus K, Antinoro L, Sacks F. A randomized controlled trial of a moderate-fat, low-energy diet compared with a low fat, low-energy diet for weight loss in overweight adults. Int J Obes Relat Metab Disord. 2001 Oct; 25(10):1503-11. PMID: 11673773.
    View in: PubMed
  227. Campos H, Moye LA, Glasser SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA. 2001 Sep 26; 286(12):1468-74. PMID: 11572739.
    View in: PubMed
  228. Tomiyasu K, Walsh BW, Ikewaki K, Judge H, Sacks FM. Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol. 2001 Sep; 21(9):1494-500. PMID: 11557678.
    View in: PubMed
  229. Bray PF, Cannon CP, Goldschmidt-Clermont P, Moyé LA, Pfeffer MA, Sacks FM, Braunwald E. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 2001 Aug 15; 88(4):347-52. PMID: 11545752.
    View in: PubMed
  230. Campos H, Perlov D, Khoo C, Sacks FM. Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res. 2001 Aug; 42(8):1239-49. PMID: 11483625.
    View in: PubMed
  231. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA. Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr. 2001 Jul; 74(1):80-9. PMID: 11451721.
    View in: PubMed
  232. Tsevat J, Kuntz KM, Orav EJ, Weinstein MC, Sacks FM, Goldman L. Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J. 2001 May; 141(5):727-34. PMID: 11320359.
    View in: PubMed
  233. Barter PJ, Sacks FM. Threshold level or not for low-density lipoprotein cholesterol. Am J Manag Care. 2001 May; 7(5 Suppl):S125-31. PMID: 11383373.
    View in: PubMed
  234. Sacks FM. Lipid-lowering therapy in acute coronary syndromes. JAMA. 2001 Apr 04; 285(13):1758-60. PMID: 11277832.
    View in: PubMed
  235. Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Kennedy E, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J. AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association. J Nutr. 2001 Apr; 131(4):1322-6. PMID: 11285345.
    View in: PubMed
  236. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, Sacks F, Rimm EB, Hunter DJ. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001 Feb 22; 344(8):549-55. PMID: 11207350.
    View in: PubMed
  237. Kris-Etherton P, Daniels SR, Eckel RH, Engler M, Howard BV, Krauss RM, Lichtenstein AH, Sacks F, St Jeor S, Stampfer M, Eckel RH, Grundy SM, Appel LJ, Byers T, Campos H, Cooney G, Denke MA, Howard BV, Kennedy E, Krauss RM, Kris-Etherton P, Lichtenstein AH, Marckmann P, Pearson TA, Riccardi G, Rudel LL, Rudrum M, Sacks F, Stein DT, Tracy RP, Ursin V, Vogel RA, Zock PL, Bazzarre TL, Clark J. Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association. Circulation. 2001 Feb 20; 103(7):1034-9. PMID: 11181482.
    View in: PubMed
  238. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001 Jan 04; 344(1):3-10. PMID: 11136953.
    View in: PubMed
  239. Vollmer WM, Sacks FM, Svetkey LP. New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products. Curr Control Trials Cardiovasc Med. 2001; 2(2):71-74. PMID: 11806776.
    View in: PubMed
  240. Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation. 2000 Oct 17; 102(16):1886-92. PMID: 11034934.
    View in: PubMed
  241. Sacks FM, Tonkin AM, Shepherd J, Braunwald E, Cobbe S, Hawkins CM, Keech A, Packard C, Simes J, Byington R, Furberg CD. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation. 2000 Oct 17; 102(16):1893-900. PMID: 11034935.
    View in: PubMed
  242. Conlin PR, Chow D, Miller ER, Svetkey LP, Lin PH, Harsha DW, Moore TJ, Sacks FM, Appel LJ. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens. 2000 Sep; 13(9):949-55. PMID: 10981543.
    View in: PubMed
  243. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000 May 09; 101(18):2149-53. PMID: 10801754.
    View in: PubMed
  244. Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, Hennekens CH. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer. 1999 Nov 01; 86(9):1783-92. PMID: 10547552.
    View in: PubMed
  245. Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton DG, Carter-Edwards L, Harsha DW. Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension. 1999 Sep; 34(3):472-7. PMID: 10489396.
    View in: PubMed
  246. Vogt TM, Appel LJ, Obarzanek E, Moore TJ, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Cutler JA, Windhauser MM, Lin PH, Karanja NM. Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc. 1999 Aug; 99(8 Suppl):S12-8. PMID: 10450289.
    View in: PubMed
  247. Svetkey LP, Sacks FM, Obarzanek E, Vollmer WM, Appel LJ, Lin PH, Karanja NM, Harsha DW, Bray GA, Aickin M, Proschan MA, Windhauser MM, Swain JF, McCarron PB, Rhodes DG, Laws RL. The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc. 1999 Aug; 99(8 Suppl):S96-104. PMID: 10450301.
    View in: PubMed
  248. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1999 Jul 20; 100(3):230-5. PMID: 10411845.
    View in: PubMed
  249. Flaker GC, Warnica JW, Sacks FM, Moyé LA, Davis BR, Rouleau JL, Webel RR, Pfeffer MA, Braunwald E. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol. 1999 Jul; 34(1):106-12. PMID: 10399998.
    View in: PubMed
  250. Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clin Cardiol. 1999 Jul; 22(7 Suppl):III6-10. PMID: 10410299.
    View in: PubMed
  251. Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherio A, Colditz GA, Rosner BA, Spiegelman D, Speizer FE, Sacks FM, Hennekens CH, Willett WC. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999 Apr 21; 281(15):1387-94. PMID: 10217054.
    View in: PubMed
  252. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999 Mar 15; 59(6):1225-30. PMID: 10096552.
    View in: PubMed
  253. Walsh BW, Spiegelman D, Morrissey M, Sacks FM. Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol. J Clin Endocrinol Metab. 1999 Mar; 84(3):985-9. PMID: 10084583.
    View in: PubMed
  254. Sacks FM, Ridker PM. Lipid lowering and beyond: results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent Events. Herz. 1999 Feb; 24(1):51-6. PMID: 10093013.
    View in: PubMed
  255. Khoo C, Campos H, Judge H, Sacks FM. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res. 1999 Feb; 40(2):202-12. PMID: 9925648.
    View in: PubMed
  256. Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, Cuddy TE, Moyé LA, Piller LB, Rutherford J, Simpson LM, Braunwald E. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation. 1999 Jan 19; 99(2):216-23. PMID: 9892586.
    View in: PubMed
  257. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999 Jan; 69(1):30-42. PMID: 9925120.
    View in: PubMed
  258. Pfeffer MA, Sacks FM, Moyé LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JL, Sussex BA, Theroux P, Vanden Belt RJ, Braunwald E. Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol. 1999 Jan; 33(1):125-30. PMID: 9935018.
    View in: PubMed
  259. Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation. 1998 Dec 08; 98(23):2513-9. PMID: 9843456.
    View in: PubMed
  260. Sacks FM. Why cholesterol as a central theme in coronary artery disease? Am J Cardiol. 1998 Nov 26; 82(10B):14T-17T. PMID: 9860368.
    View in: PubMed
  261. Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med. 1998 Nov 01; 129(9):681-9. PMID: 9841599.
    View in: PubMed
  262. Su W, Campos H, Judge H, Walsh BW, Sacks FM. Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab. 1998 Sep; 83(9):3267-76. PMID: 9745440.
    View in: PubMed
  263. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation. 1998 Sep 01; 98(9):839-44. PMID: 9738637.
    View in: PubMed
  264. Lewis SJ, Sacks FM, Mitchell JS, East C, Glasser S, Kell S, Letterer R, Limacher M, Moye LA, Rouleau JL, Pfeffer MA, Braunwald E. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol. 1998 Jul; 32(1):140-6. PMID: 9669262.
    View in: PubMed
  265. Shepherd J, Olsson AG, Sacks FM, Black DM, Orloff DG, Bilheimer DW. Should separate endpoint trials be required for all lipid-lowering drugs acting by the same mechanism? Am J Cardiol. 1998 Apr 23; 81(8A):88F-94F. PMID: 9604922.
    View in: PubMed
  266. Sacks FM, Moyé LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation. 1998 Apr 21; 97(15):1446-52. PMID: 9576424.
    View in: PubMed
  267. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ. Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension. 1998 Jan; 31(1):131-8. PMID: 9449404.
    View in: PubMed
  268. Garland M, Sacks FM, Colditz GA, Rimm EB, Sampson LA, Willett WC, Hunter DJ. The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr. 1998 Jan; 67(1):25-30. PMID: 9440371.
    View in: PubMed
  269. Campos H, Walsh BW, Judge H, Sacks FM. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab. 1997 Dec; 82(12):3955-63. PMID: 9398695.
    View in: PubMed
  270. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997 Apr 17; 336(16):1117-24. PMID: 9099655.
    View in: PubMed
  271. Moyé LA, Davis BR, Sacks F, Cole T, Brown L, Hawkins CM. Decision rules for predicting future lipid values in screening for a cholesterol reduction clinical trial. Control Clin Trials. 1996 Dec; 17(6):536-46. PMID: 8974212.
    View in: PubMed
  272. De Oliveira e Silva ER, Seidman CE, Tian JJ, Hudgins LC, Sacks FM, Breslow JL. Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr. 1996 Nov; 64(5):712-7. PMID: 8901790.
    View in: PubMed
  273. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 03; 335(14):1001-9. PMID: 8801446.
    View in: PubMed
  274. Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med. 1996 Oct 01; 125(7):529-40. PMID: 8815751.
    View in: PubMed
  275. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996 Sep 18; 276(11):882-8. PMID: 8782637.
    View in: PubMed
  276. O'Hanesian MA, Rosner B, Bishop LM, Sacks FM. Effects of inherent responsiveness to diet and day-to-day diet variation on plasma lipoprotein concentrations. Am J Clin Nutr. 1996 Jul; 64(1):53-9. PMID: 8669414.
    View in: PubMed
  277. Wilt TJ, Davis BR, Meyers DG, Rouleau JL, Sacks FM. Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology. 1996 Jun; 47(6):533-41. PMID: 8678327.
    View in: PubMed
  278. Ascherio A, Hennekens C, Willett WC, Sacks F, Rosner B, Manson J, Witteman J, Stampfer MJ. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension. 1996 May; 27(5):1065-72. PMID: 8621198.
    View in: PubMed
  279. Ascherio A, Cho E, Walsh K, Sacks FM, Willett WC, Faruqui A. Premature coronary deaths in Asians. BMJ. 1996 Feb 24; 312(7029):508. PMID: 8597699; PMCID: PMC2349932.
  280. Sacks FM, Krukonis GP. The influence of apolipoprotein E on the interactions between normal human very low density lipoproteins and U937 human macrophages: heterogeneity among persons. Vasc Med. 1996; 1(1):9-18. PMID: 9546921.
    View in: PubMed
  281. Sacks FM, Brown LE, Appel L, Borhani NO, Evans D, Whelton P. Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension. 1995 Dec; 26(6 Pt 1):950-6. PMID: 7490154.
    View in: PubMed
  282. Sacks FM. Dietary approaches to stop hypertension. Ann Epidemiol. 1995 Nov; 5(6):502. PMID: 8680615.
    View in: PubMed
  283. Pfeffer MA, Sacks FM, Moyé LA, Brown L, Rouleau JL, Hartley LH, Rouleau J, Grimm R, Sestier F, Wickemeyer W, et al. Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol. 1995 Sep 28; 76(9):98C-106C. PMID: 7572695.
    View in: PubMed
  284. Sacks FM, Gibson CM, Rosner B, Pasternak RC, Stone PH. The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group. Am J Cardiol. 1995 Sep 28; 76(9):78C-85C. PMID: 7572692.
    View in: PubMed
  285. Sacks FM. Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol. 1995 Jun 15; 75(17):1263-4. PMID: 7778551.
    View in: PubMed
  286. Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol. 1995 Jun; 25(7):1492-8. PMID: 7759696.
    View in: PubMed
  287. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995 Jun; 61(6 Suppl):1402S-1406S. PMID: 7754995.
    View in: PubMed
  288. Sacks FM, Gerhard M, Walsh BW. Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol. 1995 Jun; 6(3):161-6. PMID: 7648005.
    View in: PubMed
  289. Sacks FM, Rouleau JL, Moye LA, Pfeffer MA, Warnica JW, Arnold JM, Nash DT, Brown LE, Sestier F, Rutherford J, et al. Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels. Am J Cardiol. 1995 Mar 15; 75(8):621-3. PMID: 7887392.
    View in: PubMed
  290. Yamamoto ME, Applegate WB, Klag MJ, Borhani NO, Cohen JD, Kirchner KA, Lakatos E, Sacks FM, Taylor JO, Hennekens CH. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar; 5(2):96-107. PMID: 7795837.
    View in: PubMed
  291. Whelton PK, Buring J, Borhani NO, Cohen JD, Cook N, Cutler JA, Kiley JE, Kuller LH, Satterfield S, Sacks FM, et al. The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol. 1995 Mar; 5(2):85-95. PMID: 7795836.
    View in: PubMed
  292. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer WM, McCullough M, Karanja N, Lin PH, Steele P, Proschan MA, et al. Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol. 1995 Mar; 5(2):108-18. PMID: 7795829.
    View in: PubMed
  293. Michels K, Sacks F. Trans fatty acids in European margarines. N Engl J Med. 1995 Feb 23; 332(8):541-2. PMID: 7830748.
    View in: PubMed
  294. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol. 1995 Feb; 25(2):387-94. PMID: 7829792.
    View in: PubMed
  295. Walsh BW, Li H, Sacks FM. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res. 1994 Nov; 35(11):2083-93. PMID: 7868986.
    View in: PubMed
  296. Sacks FM, Pasternak RC, Gibson CM, Rosner B, Stone PH. Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients. Harvard Atherosclerosis Reversibility Project (HARP) Group. Lancet. 1994 Oct 29; 344(8931):1182-6. PMID: 7934538.
    View in: PubMed
  297. Sacks F. Dietary fats and coronary heart disease. J Cardiovasc Risk. 1994 Jun; 1(1):3-8. PMID: 7614414.
    View in: PubMed
  298. Sacks FM, Walsh BW. Sex hormones and lipoprotein metabolism. Curr Opin Lipidol. 1994 Jun; 5(3):236-40. PMID: 7952919.
    View in: PubMed
  299. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med. 1994 May 23; 154(10):1106-10. PMID: 8185424.
    View in: PubMed
  300. Eaker E, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Special report: cardiovascular disease in women. Special writing group. Heart Dis Stroke. 1994 Mar-Apr; 3(2):114-9. PMID: 8199764.
    View in: PubMed
  301. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 1994 Feb 16; 86(4):281-6. PMID: 8158682.
    View in: PubMed
  302. Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ, et al. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. J Hypertens. 1994 Feb; 12(2):209-13. PMID: 8021472.
    View in: PubMed
  303. Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ, et al. The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. J Hypertens Suppl. 1994; 12(7):S23-31. PMID: 7769501.
    View in: PubMed
  304. Litin L, Sacks F. Trans-fatty-acid content of common foods. N Engl J Med. 1993 Dec 23; 329(26):1969-70. PMID: 8247070.
    View in: PubMed
  305. Ridker PM, Vaughan DE, Stampfer MJ, Sacks FM, Hennekens CH. A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100. Arterioscler Thromb. 1993 Nov; 13(11):1587-92. PMID: 8218099.
    View in: PubMed
  306. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993 Oct; 88(4 Pt 1):1999-2009. PMID: 8403349.
    View in: PubMed
  307. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism. 1993 Sep; 42(9):1153-8. PMID: 8412768.
    View in: PubMed
  308. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation. 1993 Aug; 88(2):523-33. PMID: 8339414.
    View in: PubMed
  309. Sacks FM. Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med. 1993 Jul-Aug; 9(4):259-60. PMID: 8398227.
    View in: PubMed
  310. London SJ, Sacks FM, Stampfer MJ, Henderson IC, Maclure M, Tomita A, Wood WC, Remine S, Robert NJ, Dmochowski JR, et al. Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst. 1993 May 19; 85(10):785-93. PMID: 8487323.
    View in: PubMed
  311. Walsh BW, Sacks FM. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest. 1993 May; 91(5):2126-32. PMID: 8486779; PMCID: PMC288213.
  312. Stone PH, Gibson CM, Pasternak RC, McManus K, Diaz L, Boucher T, Spears R, Sandor T, Rosner B, Sacks FM. Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group. Am J Cardiol. 1993 Apr 01; 71(10):766-72. PMID: 8456751.
    View in: PubMed
  313. Gibson CM, Diaz L, Kandarpa K, Sacks FM, Pasternak RC, Sandor T, Feldman C, Stone PH. Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb. 1993 Feb; 13(2):310-5. PMID: 8427866.
    View in: PubMed
  314. Morris MC, Taylor JO, Stampfer MJ, Rosner B, Sacks FM. The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am J Clin Nutr. 1993 Jan; 57(1):59-64. PMID: 8416666.
    View in: PubMed
  315. Ascherio A, Rimm EB, Giovannucci EL, Colditz GA, Rosner B, Willett WC, Sacks F, Stampfer MJ. A prospective study of nutritional factors and hypertension among US men. Circulation. 1992 Nov; 86(5):1475-84. PMID: 1330360.
    View in: PubMed
  316. Caine YG, Bauer KA, Barzegar S, ten Cate H, Sacks FM, Walsh BW, Schiff I, Rosenberg RD. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost. 1992 Oct 05; 68(4):392-5. PMID: 1333098.
    View in: PubMed
  317. Sacks FM. Desirable serum total cholesterol with low HDL cholesterol levels. An undesirable situation in coronary heart disease. Circulation. 1992 Oct; 86(4):1341-4. PMID: 1394943.
    View in: PubMed
  318. Gibson CM, Sandor T, Stone PH, Pasternak RC, Rosner B, Sacks FM. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 1992 May 15; 69(16):1286-90. PMID: 1585861.
    View in: PubMed
  319. Hunter DJ, Rimm EB, Sacks FM, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol. 1992 Feb 15; 135(4):418-27. PMID: 1550093.
    View in: PubMed
  320. Sacks FM, Willett WW. More on chewing the fat. The good fat and the good cholesterol. N Engl J Med. 1991 Dec 12; 325(24):1740-2. PMID: 1944476.
    View in: PubMed
  321. Sacks FM, Pfeffer MA, Moye' L, Brown LE, Hamm P, Cole TG, Hawkins CM, Braunwald E. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) Am J Cardiol. 1991 Dec 01; 68(15):1436-46. PMID: 1746424.
    View in: PubMed
  322. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991 Oct 24; 325(17):1196-204. PMID: 1922206.
    View in: PubMed
  323. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991 Aug 08; 325(6):373-81. PMID: 2062328.
    View in: PubMed
  324. London SJ, Sacks FM, Caesar J, Stampfer MJ, Siguel E, Willett WC. Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr. 1991 Aug; 54(2):340-5. PMID: 1858698.
    View in: PubMed
  325. Silverman DI, Ware JA, Sacks FM, Pasternak RC. Comparison of the absorption and effect on platelet function of a single dose of n-3 fatty acids given as fish or fish oil. Am J Clin Nutr. 1991 May; 53(5):1165-70. PMID: 1826984.
    View in: PubMed
  326. Willett W, Sacks FM. Chewing the fat--how much and what kind? N Engl J Med. 1991 Jan 10; 324(2):121-3. PMID: 1984177.
    View in: PubMed
  327. Reis GJ, Silverman DI, Boucher TM, Sipperly ME, Horowitz GL, Sacks FM, Pasternak RC. Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am J Cardiol. 1990 Nov 15; 66(17):1171-5. PMID: 2239719.
    View in: PubMed
  328. Silverman DI, Reis GJ, Sacks FM, Boucher TM, Pasternak RC. Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol. 1990 Oct 01; 66(10):860-2. PMID: 2145737.
    View in: PubMed
  329. Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Kok FJ, Sacks FM, Speizer FE, Rosner B, Hennekens CH. Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol. 1990 Mar 01; 65(9):633-7. PMID: 2309634.
    View in: PubMed
  330. Swain JF, Rouse IL, Curley CB, Sacks FM. Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med. 1990 Jan 18; 322(3):147-52. PMID: 2152973.
    View in: PubMed
  331. Sacks FM, Walsh BW. The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci. 1990; 592:272-85; discussion 334-45. PMID: 2375589.
    View in: PubMed
  332. Hankinson SE, London SJ, Chute CG, Barbieri RL, Jones L, Kaplan LA, Sacks FM, Stampfer MJ. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem. 1989 Dec; 35(12):2313-6. PMID: 2591049.
    View in: PubMed
  333. Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, Rosner B, Hennekens CH. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989 Nov; 80(5):1320-7. PMID: 2805268.
    View in: PubMed
  334. Alderman JD, Pasternak RC, Sacks FM, Smith HS, Monrad ES, Grossman W. Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol. 1989 Oct 01; 64(12):725-9. PMID: 2801522.
    View in: PubMed
  335. Sacks FM. Dietary fats and blood pressure: a critical review of the evidence. Nutr Rev. 1989 Oct; 47(10):291-300. PMID: 2689919.
    View in: PubMed
  336. Reis GJ, Boucher TM, Sipperly ME, Silverman DI, McCabe CH, Baim DS, Sacks FM, Grossman W, Pasternak RC. Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet. 1989 Jul 22; 2(8656):177-81. PMID: 2568519.
    View in: PubMed
  337. Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension. Am J Med. 1989 Jan 23; 86(1B):8-13. PMID: 2563311.
    View in: PubMed
  338. Figge HL, Figge J, Souney PF, Sacks FM, Shargel L, Janosik JE, Kaul AF. Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J Clin Pharmacol. 1988 Dec; 28(12):1136-40. PMID: 3243933.
    View in: PubMed
  339. Kushi LH, Samonds KW, Lacey JM, Brown PT, Bergan JG, Sacks FM. The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol. 1988 Nov; 128(5):1054-64. PMID: 3189281.
    View in: PubMed
  340. Sacks FM, Kass EH. Low blood pressure in vegetarians: effects of specific foods and nutrients. Am J Clin Nutr. 1988 Sep; 48(3 Suppl):795-800. PMID: 3414588.
    View in: PubMed
  341. Stampfer MJ, Sacks FM. Patch up the menopause. Lancet. 1988 Jun 11; 1(8598):1332. PMID: 2897573.
    View in: PubMed
  342. Figge HL, Figge J, Souney PF, Mutnick AH, Sacks F. Nicotinic acid: a review of its clinical use in the treatment of lipid disorders. Pharmacotherapy. 1988; 8(5):287-94. PMID: 3075276.
    View in: PubMed
  343. Sacks FM, Rouse IL, Stampfer MJ, Bishop LM, Lenherr CF, Walther RJ. Effect of dietary fats and carbohydrate on blood pressure of mildly hypertensive patients. Hypertension. 1987 Oct; 10(4):452-60. PMID: 3308702.
    View in: PubMed
  344. Sacks FM, Stampfer MJ, Munoz A, McManus K, Canessa M, Kass EH. Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr. 1987 Apr; 6(2):179-85. PMID: 3584738.
    View in: PubMed
  345. Dzau VJ, Sacks FM. Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol. 1987; 10 Suppl 9:S2-6. PMID: 2447436.
    View in: PubMed
  346. Sacks FM, Breslow JL. Very low density lipoproteins stimulate cholesteryl ester formation in U937 macrophages. Heterogeneity and biologic variation among normal humans. Arteriosclerosis. 1987 Jan-Feb; 7(1):35-46. PMID: 3813975.
    View in: PubMed
  347. Sacks FM, Handysides GH, Marais GE, Rosner B, Kass EH. Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med. 1986 Aug; 146(8):1573-7. PMID: 3729638.
    View in: PubMed
  348. Sacks FM, Dzau VJ. Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med. 1986 Feb 14; 80(2A):71-81. PMID: 3080883.
    View in: PubMed
  349. Sacks FM, Ornish D, Rosner B, McLanahan S, Castelli WP, Kass EH. Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA. 1985 Sep 13; 254(10):1337-41. PMID: 4021011.
    View in: PubMed
  350. Sacks FM, Kass EH. Eggs and cholesterol. Lancet. 1984 May 26; 1(8387):1191. PMID: 6144920.
    View in: PubMed
  351. Sacks FM, Salazar J, Miller L, Foster JM, Sutherland M, Samonds KW, Albers JJ, Kass EH. Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet. 1984 Mar 24; 1(8378):647-9. PMID: 6142348.
    View in: PubMed
  352. Sacks FM, Wood PG, Kass EH. Stability of blood pressure in vegetarians receiving dietary protein supplements. Hypertension. 1984 Mar-Apr; 6(2 Pt 1):199-201. PMID: 6724661.
    View in: PubMed
  353. Sacks FM, Marais GE, Handysides G, Salazar J, Miller L, Foster JM, Rosner B, Kass EH. Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension. 1984 Mar-Apr; 6(2 Pt 1):193-8. PMID: 6724660.
    View in: PubMed
  354. Sacks FM, Breslow JL, Wood PG, Kass EH. Lack of an effect of dairy protein (casein) and soy protein on plasma cholesterol of strict vegetarians. An experiment and a critical review. J Lipid Res. 1983 Aug; 24(8):1012-20. PMID: 6685165.
    View in: PubMed
  355. Sacks FM. Effects of foods consumed on plasma cholesterol levels. Am J Clin Nutr. 1983 May; 37(5):883-4. PMID: 6846230.
    View in: PubMed
  356. Sacks FM, Donner A, Castelli WP, Gronemeyer J, Pletka P, Margolius HS, Landsberg L, Kass EH. Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA. 1981 Aug 07; 246(6):640-4. PMID: 7019459.
    View in: PubMed
  357. Altman KA, Sacks F. Bronchopneumonia and endocarditis: caused by Acinetobacter anitratum (Herellea vaginicola). N Y State J Med. 1979 Aug; 79(9):1434-5. PMID: 291811.
    View in: PubMed
  358. Sacks FM, Castelli WP, Donner A, Kass EH. Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med. 1975 May 29; 292(22):1148-51. PMID: 164628.
    View in: PubMed
  359. Zinner SH, Martin LF, Sacks F, Rosner B, Kass EH. A longitudinal study of blood pressure in childhood. Am J Epidemiol. 1974 Dec; 100(6):437-42. PMID: 4447107.
    View in: PubMed
  360. Sacks FM, Rosner B, Kass EH. Blood pressure in vegetarians. Am J Epidemiol. 1974 Nov; 100(5):390-8. PMID: 4418801.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu). HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sacks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_